Skip to main content

World Cancer Day 2024: A Live Panel Discussion

Oncology Data Advisor® · World Cancer Day 2024 with Oncology Data Advisor In honor of World Cancer Day on February 4, members of the Oncology Data Advisor Fellows Forum and Editorial Board joined forces for a thought-provoking discussion about improving cancer care on a global scale, including treatment access, molecular testing, clinical trial diversity, and patient advocacy worldwide.   Oncology Data Advisor: All right, everyone, thank you so much for tuning into today's World ...

Continue reading

Introducing the Oncology Data Advisor® Fellows Forum: A Valuable Resource for Hematology/Oncology Fellows With Samuel Kareff, MD, MPH

Oncology Data Advisor® · Fellows Forum: A Valuable Resource for Hematology/Oncology Fellows Oncology Data Advisor® is excited to announce the launch of the Fellows Forum, a new resource featuring expert perspectives geared toward Hematology/Oncology Fellows. In this interview, Dr. Samuel Kareff, Chief Hematology/Oncology Fellow at the University of Miami's Sylvester Cancer Center, discusses the educational topics that he is looking forward to sharing his insights on as a Fellows Forum...

Continue reading

Highlights from the San Antonio Breast Cancer Symposium With Jason Mouabbi, MD

At the recent San Antonio Breast Cancer Symposium (SABCS), researchers from around the world presented breaking developments in the treatment and care of patients with breast cancer. In this interview, Dr. Jason Mouabbi, an Assistant Professor in the Development of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, shares the four abstracts which he believes will have the greatest impact on practice in the year to come. Oncology Data Advisor: Welcome to Oncology D...

Continue reading

New Lung Cancer Screening Guidelines With Brian Whang, MD, FACS

Recently, the American Cancer Society recommended new lung cancer screening guidelines to shift the focus from quitting smoking, to helping all individuals who have smoked despite quitting 20 to 30 years prior. In this interview, Dr. Brian Whang, Medical Director of Lung Cancer Screening for Hartford Healthcare, discusses these new guidelines, what they mean, and why we should continue advocating for better lung cancer screening guidelines and awareness of this issue.   Oncology Data Adviso...

Continue reading

Implementing Hepatic Artery Infusion Pump Programs With Sepideh Gholami, MD, MAS, FACS, FSSO

Oncology Data Advisor® · Implementing Hepatic Artery Infusion Pump Programs With Sepideh Gholami, MD, MAS, FACS, FSSO Recently, Sepideh Gholami implemented a Hepatic Artery Infusion Pump Program at Northwell Health. In this interview, Dr. Gholami discusses what exactly a hepatic artery infusion pump is, its benefits, and how it will affect the future treatment landscape of cancers as a whole. As well, she advocates for the implementation of these programs in more institutions across t...

Continue reading

Exploring Educational Opportunities During Hematology/Oncology Fellowship With Matthew Hadfield, DO, and Richa Thakur, MD

In this Oncology Data Advisor Fellows Forum interview, Dr. Matthew Hadfield, Medical Oncology Fellow at Brown University, and Dr. Richa Thakur, Hematology/Oncology Fellow at Northwell Health, explore the different types of educational opportunities available during fellowship, including podcasts and in-person meetings, and strategies for finding the most up-to-date education. Visit i3Health.com to explore the FREE live hematology/oncology meeting series offered by i3 Health, and book one fo...

Continue reading

The Importance of Exercise for Cancer Survivorship With Nagashree Seetharamu, MD, MBBS

Oncology Data Advisor® · The Importance of Exercise for Cancer Survivorship With Nagashree Seetharamu In this interview, Dr. Nagashree Seetharamu, MD, MBBS, a Professor in the Division of Hematology and Medical Oncology in the Department of Medicine at Hofstra Northwell Health, sat down to discuss the vital role that exercise takes in the cancer treatment and recovery process. As well, she shares advice on why an individualized approach to a patient's exercise routine and care is cruc...

Continue reading

Exploring Educational Opportunities During Hematology/Oncology Fellowship With Matthew Hadfield, DO, and Richa Thakur, MD

Oncology Data Advisor® · Exploring Opportunities During Hematology/Oncology Fellowship With Matthew Hadfield and Richa Thakur In this Oncology Data Advisor Fellows Forum interview, Dr. Matthew Hadfield, Medical Oncology Fellow at Brown University, and Dr. Richa Thakur, Hematology/Oncology Fellow at Northwell Health, explore the different types of educational opportunities available during fellowship, including podcasts and in-person meetings, and strategies for finding the most up-to-...

Continue reading

Harnessing Precision Medicine in Oncology With Ofer Sharon, MD

Oncology Data Advisor® · Harnessing Precision Medicine in Oncology With Ofer Sharon, MD In this interview, Ofer Sharon, MD, the CEO of OncoHost, explains the unique opportunities for harnessing precision medicine in oncology, the unmet needs regarding biomarker development, and the potential of utilizing a multicomponent biomarker approach for understanding the mechanisms of therapy resistance and developing novel pathways for treatment.   Oncology Data Advisor: Welcome to Oncolo...

Continue reading

Partnering With Patients: A Collection of Perspectives From ASCO 2023

Oncology Data Advisor holds the utmost value for patient advocates and advocacy groups as they strive to prioritize patient-centered care and shared decision making throughout the cancer journey. At this year's American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor spoke with numerous individuals representing diverse aspects of oncology and asked them how they strive to partner with patients in their practice, research, and advocacy work.   Allison Rosen, Patient...

Continue reading

Exploring Hot Topics in Radiation Oncology With John Hillson, RN, BSN, OCN®

Oncology Data Advisor® · Exploring Hot Topics in Radiation Oncology With John Hillson, RN, BSN, OCN At the recent 48th Annual Oncology Nursing Society (ONS) Congress, John Hillson, an Oncology Certified Nurse, presented his research titled Hot Topics in Radiation Oncology, in which he and colleagues expanded upon the rapidly evolving field of radiation oncology and why it is important to stay on top of understanding this field.   Oncology Data Advisor: Welcome to Oncology Data Ad...

Continue reading

Highlights of ONS Congress 2023 With Maria Badillo, MSN, RN, OCN®, CCRP

This year's Oncology Nursing Society (ONS) Congress featured numerous thought-provoking and motivating presentations from experts in the field of oncology nursing. Maria Badillo, Research Nurse Manager at MD Anderson Cancer Center and Editorial Board Member of Oncology Data Advisor®, stopped by in between presentations to share the most inspiring topics that she enjoyed hearing and is looking forward to sharing with her team.   Oncology Data Advisor: Welcome to Oncology Data Advisor. Today ...

Continue reading

Introducing the Oncology Data Advisor® Fellows Forum: A Valuable Resource for Hematology/Oncology Fellows With Samuel Kareff, MD, MPH

Oncology Data Advisor® is excited to announce the launch of the Fellows Forum, a new resource featuring expert perspectives geared toward Hematology/Oncology Fellows. In this interview, Dr. Samuel Kareff, Chief Hematology/Oncology Fellow at the University of Miami's Sylvester Cancer Center, shares the educational topics that he is looking forward to sharing his insights on as a Fellows Forum member, including tips for fellowship application, specialty pros and cons, research advances, and collaborations with policymakers and patient advocacy groups.  

Continue reading

FDA Oncology Approvals in 2022: Timeline of Novel Treatment Options

The past year has been filled with new and exciting improvements and novel treatment options in the field of oncology and hematology. The FDA has granted approval and accelerated approval to many new drugs and drug combinations, including the very first approval for patients with HER2-mutant non–small cell lung cancer, trastuzumab deruxtecan. This is a great time to reflect on the current treatment landscape and ponder what 2023 could have in store for future approvals and emerging treatment opt...

Continue reading

Emphasizing Communication and Expectations for Lung Cancer Side Effects With Blanca Ledezma, MSN, NP

With the advent of targeted therapies in lung cancer, patients are experiencing improved outcomes through personalized medicine. However, education regarding potential toxicity is crucial. In this interview, Blanca Ledezma, MSN, NP, shares the importance of setting up expectations for the side effects of targeted therapies for lung cancer and emphasizing communication with the health care team throughout the course of treatment.  

Continue reading

Please Move: Get Your Oncology Patients Exercising With Karen Basen-Engquist, PhD, MPH

At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Karen Basen-Engquist, PhD, MPH, Director of the Center for Energy Balance in Cancer Prevention and Survivorship at The University of Texas MD Anderson Cancer Center, sat down with Oncology Data Advisor after presenting her education session on behavioral strategies to get your patients with cancer exercising and why it is important.  

Continue reading

Garnering Knowledge Gains for Treatment of Advanced Renal Cell Carcinoma

An educational enduring live meeting series and online activity provided by i3 Health has demonstrated knowledge gains encompassing the nurse's perspective of evolving treatment paradigms in advanced renal cell carcinoma (RCC). Kidney cancer is among the top 10 most common cancers in the United States, accounting for approximately 4% of all cancer diagnoses in the US. The American Cancer Society predicted that in 2022, 79,000 new cases of kidney cancer would be diagnosed, with 13,920 of these ca...

Continue reading

Creating an Inclusive Environment in Your Oncology Practice With Mark Fleming, MD

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, Dr. Mark T. Fleming and colleagues, from the Virginia Oncology Associates, presented their poster about their initiative to foster a culture of inclusion in an independent community oncology and hematology practice that specializes in the diagnosis and treatment of cancer and blood disorders.  

Continue reading

A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD: May 2022

From my perch atop the masthead at Oncology Data Advisor, I am awed by the dozens of oncology professionals who give freely of their time and expertise to inform our readership of the latest in their respective areas. Their efforts are what make ODA a premier online resource for all things in this ever-evolving field. My heartfelt thanks go to these wonderful colleagues without whom we would cease to be a publication. In this month's Editor's Letter, I would like to highlight a few of the outsta...

Continue reading

A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD

It is my pleasure to assume the post of Editor in Chief of Oncology Data Advisor for 2022. One of the perks of this role is the opportunity to speak directly to you, the readership, about everything we are up to here. Not only do we strive to give you trenchant summaries of the latest and most relevant oncology treatment breakthroughs in print, podcast, and video formats, but we also aim to give you insights into where our experts believe oncology is headed and what hurdles need to be cleared be...

Continue reading